Advertisement
Screener

PALISADE BIO, INC. (PALI) Shares Outstanding (Cover Page)

2.8 / 5 stars · 68/120 Roast Me

PALISADE BIO, INC. Shares Outstanding (Cover Page)

PALISADE BIO, INC. (PALI) had Shares Outstanding (Cover Page) of 174.27 million shares as of 2026-08-06, per its 10-Q filed 2026-08-10.

Financial Statements › Notes › Cover Page

dei:EntityCommonStockSharesOutstanding · last filed 2026-08-10

  • 2026-08-06: Entity Common Stock, Shares Outstanding 174.27M shares.
  • 2026-05-07: Entity Common Stock, Shares Outstanding 173.58M shares.
  • 2026-03-18: Entity Common Stock, Shares Outstanding 165.88M shares.
  • 2025-11-05: Entity Common Stock, Shares Outstanding 149.00M shares.
Period endEntity Common Stock, Shares OutstandingEntity Common Stock, Shares Outstanding as first filed
2026-08-06174.27M shares
10-Q · filed 2026-08-10
2026-05-07173.58M shares
10-Q · filed 2026-05-12
2026-03-18165.88M shares
10-K · filed 2026-03-20
2025-11-05149.00M shares
10-Q · filed 2025-11-10
2025-08-079.12M shares
10-Q · filed 2025-08-11
2025-05-084.80M shares
10-Q · filed 2025-05-12
2025-03-194.40M shares
10-K · filed 2025-03-24
2024-11-071.33M shares
10-Q · filed 2024-11-12
2024-08-051.18M shares
10-Q · filed 2024-08-12
2024-05-08937.56K shares
10-Q · filed 2024-05-13
2024-03-2112.77M shares
10-K · filed 2024-03-26
2023-11-069.22M shares
10-Q · filed 2023-11-09
2023-08-086.86M shares
10-Q · filed 2023-08-10
2023-05-086.70M shares
10-Q · filed 2023-05-11
2023-03-154.50M shares
10-K · filed 2023-03-22
2022-11-1077.08M shares
10-Q · filed 2022-11-14
2022-08-1121.88M shares
10-Q · filed 2022-08-15
2022-05-1021.88M shares
10-Q · filed 2022-05-13
2022-03-1618.23M shares
10-K · filed 2022-03-17
2021-11-1013.57M shares
10-Q · filed 2021-11-12
2021-08-2012.91M shares
10-Q/A · filed 2021-09-14
11.40M shares
10-Q · filed 2021-08-23
2021-05-057.30M shares
10-Q · filed 2021-05-14
2021-02-2817.30M shares
10-K · filed 2021-03-22
2020-10-3117.30M shares
10-Q · filed 2020-11-10
2020-07-3117.30M shares
10-Q · filed 2020-08-13
2020-04-309.43M shares
10-Q · filed 2020-05-15
2020-02-299.43M shares
10-K · filed 2020-03-27
2019-11-053.87M shares
10-Q · filed 2019-11-14
2019-08-082.10M shares
10-Q · filed 2019-08-14
2019-04-3020.01M shares
10-Q · filed 2019-05-14
2019-02-2818.21M shares
10-K · filed 2019-03-22
2018-10-3118.21M shares
10-Q · filed 2018-11-14
2018-07-3115.16M shares
10-Q · filed 2018-08-13
2018-04-3015.16M shares
10-Q · filed 2018-05-15
2018-02-2815.16M shares
10-K · filed 2018-04-02
2017-10-3115.15M shares
10-Q · filed 2017-11-08
2017-07-3112.12M shares
10-Q · filed 2017-08-08
2017-04-3011.90M shares
10-Q · filed 2017-05-10
2017-02-2811.05M shares
10-K · filed 2017-03-23
2016-10-31114.86M shares
10-Q · filed 2016-11-08
2016-07-31114.76M shares
10-Q · filed 2016-08-11
2016-04-3092.04M shares
10-Q · filed 2016-05-09
2016-03-0192.04M shares
10-K · filed 2016-03-14
2015-10-3191.79M shares
10-Q · filed 2015-11-09
2015-07-3191.79M shares
10-Q · filed 2015-08-10
2015-04-3090.34M shares
10-Q · filed 2015-05-08
2015-02-2889.70M shares
10-K · filed 2015-03-16
2014-10-3187.36M shares
10-Q · filed 2014-11-07
2014-07-3186.84M shares
10-Q · filed 2014-08-08
2014-04-3086.76M shares
10-Q · filed 2014-05-12
2014-02-2886.22M shares
10-K · filed 2014-03-10
2013-10-3176.66M shares
10-Q · filed 2013-11-12
2013-07-3171.65M shares
10-Q · filed 2013-08-08
2013-04-3068.80M shares
10-Q · filed 2013-05-10
2013-02-2868.45M shares
10-K · filed 2013-03-15
2012-10-3167.99M shares
10-Q · filed 2012-11-09
2012-07-3154.10M shares
10-Q · filed 2012-08-09
2012-05-0754.10M shares
10-Q · filed 2012-05-09
2012-03-0153.88M shares
10-K · filed 2012-03-30
2011-11-0148.68M shares
10-Q · filed 2011-11-09
2011-08-0148.49M shares
10-Q/A · filed 2011-09-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Liminatus Pharma, Inc. (LIMN)United States$0.282B
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35